Erratum: The validity and clinical utility of night eating syndrome



This article corrects:

  1. The validity and clinical utility of night eating syndrome Volume 42, Issue 8, 720–738, Article first published online: 20 July 2009

In the article “The Validity and Clinical Utility of Night Eating Syndrome” (DOI: 10.1002/eat.20721, Striegel-Moore, et al., volume 42, pp. 720–738), the information on Comorbidity of Night Eating Synrdome (NES) and Binge Eating Disorder (BED) or Bulimia Nervosa (BN) as shown in Table 3 should be corrected as follows:

Jarrosz et al. (2007, reference # 37) reported that among individuals with NES, 5.6% met diagnostic criteria for BED and 5.6% met criteria for BN. Among individuals with BED, 25% met criteria for NES; among individuals with BN, 20% met criteria for NES.

Allison et al. (2007, reference # 33) reported that among individuals with NES, 9.4% met criteria for BED; among individuals with BED, 25% met criteria for NES.

Allison et al. (2006, reference # 26) reported that among individuals with NES, 0% met criteria for BN and among individuals with BN, 0% met criteria for NES.

In Table 3, reference # 27 (Lundgren et al., 2006) should be # 28.

Corrected Table 3 is shown below:

Table 3. Comorbidity of night eating syndrome (NES) and Bulimia nervosa (BN) or binge eating disorder (BED)
StudyStudy SampleInstrument Used for Diagnosis of NESInstrument Used for Diagnosis Od BED% BED in NES (% BN in NES)%NES in BED (% NES in BN)
  • Notes: DNA = does not apply; EDE = Eating Disorder Examination62; IDED-IV = Interview for Diagnosing Eating Disorders, 4th edition63; NESQ = Weight and Lifestyle: Night Eating Syndrome Questionnaire61; NESHI = Night Eating Syndrome History and Inventory, unpublished; QEWP-R = Questionnaire on Eating and Weight Patterns.64

  • a

    Excluded individuals currently on psychotropic medication, or individuals currently enrolled in a weight loss program.

  • b

    Excluded individuals currently in other psychosocial treatments, individuals with medical conditions affecting weight (e.g., diabetes), and individuals with severe psychiatric comobidities including psychosis, bipolar disorder, acute suicidality, and current substance dependence.

  • c

    Only nocturnal eating was assessed; for the purpose of this table NES was considered present consistent with the “symptom” definition of NES requiring at least three noncturnal eating episodes/week.

Lundgren et al.28103 NES patientsaNESHIEDE19.4%DNA
Grilo and Masheb56207 Outpatients with BEDbEDEcEDEDNA9.2%
Napolitano et al.1783 Obese outpatientsClinical interviewIDED-IV36%50%
Adami et al.18166 Obese outpatientsClinical interviewClinical interview50%24.1%
Jarosz et al.3796 Obese outpatients (all African American)NESQQEWP-R5.6% (5.6%)25% (20%)
Allison et al.33845 Overweight patients with Type 2 diabetesNESHIEDE9.4%25%
Colles et al.36431 Individuals, including 158 obese community members, 93 obese support group members, 180 bariatric surgery candidatesClinical interviewClinical interview40%37%
Allison et al.26216 Bariatric surgery candidatesClinical interviewClinical interview26% (0)41.7% (0)